CANCER DIGEST – Feb. 8, 2020 – A new study in three patients with advanced cancer has shown that directly editing T cells to fight cancer can be done safely.
Many advances in immunotherapy approaches have been achieved Credit Mayo Clinic
Saturday, February 8, 2020
Saturday, January 25, 2020
New combination therapy may overcome HER2 resistance
![]() |
|
Dhivya Sudhan, Ph.D., (left) and Carlos L. Arteaga, M.D. –
Credit UT Southwestern |
“This finding may give clinicians an effective response to neratinib resistance,” Carlos L. Arteaga, M.D., Director of the Simmons Cancer Center at UT Southwestern said in a press release. "That could make a real difference for patients with breast, ovarian, lung, and other cancers harboring HER2 mutations."
Friday, January 17, 2020
Report shows steady decline in cancer death rates
| Graph credit ACS |
Overall cancer death rates dropped by an average of 1.5 percent per year during the most recent decade of data (2008-2017), continuing a trend that began in the early 1990s and resulting in the 29 percent drop in cancer mortality in that time.
Saturday, January 11, 2020
Zapping cancer in a single treatment: FLASH therapy is feasible
| Photo credit–Roberts Proton Therapy Center |
For current cancer patients who undergo their radiation treatments over the course of weeks, such a treatment might seem impossible, but researchers at Penn Medicine say they have demonstrated the ability to deliver an entire course of radiation in less than a second.
Saturday, January 4, 2020
Single course chemo is effective for preventing testicular cancer
![]() |
| Image credit – MedlinePlus |
The study led by the Institute of Cancer Research, London and University Hospitals Birmingham NHS Foundation trust involved nearly 250 men with early stage testicular cancer at high risk of their cancer returning. The results appear in the Jan. 1, 2020 journal European Urology
Subscribe to:
Posts (Atom)


